[HTML][HTML] A survey of renal impairment pharmacokinetic studies for new oncology drug approvals in the USA from 2010 to early 2015: a focus on development …
JJ Xiao, JS Chen, BL Lum, RA Graham - Anti-Cancer Drugs, 2017 - journals.lww.com
Abstract The US Food and Drug Administration (FDA) issued a guidance document in 2010
on pharmacokinetic (PK) studies in renal impairment (RI) on the basis of observations that …
on pharmacokinetic (PK) studies in renal impairment (RI) on the basis of observations that …
A survey of renal impairment pharmacokinetic studies for new oncology drug approvals in the USA from 2010 to early 2015: a focus on development strategies and …
JJ Xiao, JS Chen, BL Lum, RA Graham - Anti-Cancer Drugs, 2017 - ingentaconnect.com
The US Food and Drug Administration (FDA) issued a guidance document in 2010 on
pharmacokinetic (PK) studies in renal impairment (RI) on the basis of observations that …
pharmacokinetic (PK) studies in renal impairment (RI) on the basis of observations that …
A survey of renal impairment pharmacokinetic studies for new oncology drug approvals in the USA from 2010 to early 2015: a focus on development strategies and …
JJ Xiao, JS Chen, BL Lum, RA Graham - Anti-cancer Drugs, 2017 - europepmc.org
Abstract The US Food and Drug Administration (FDA) issued a guidance document in 2010
on pharmacokinetic (PK) studies in renal impairment (RI) on the basis of observations that …
on pharmacokinetic (PK) studies in renal impairment (RI) on the basis of observations that …
A survey of renal impairment pharmacokinetic studies for new oncology drug approvals in the USA from 2010 to early 2015: a focus on development strategies and …
JJ Xiao, JS Chen, BL Lum… - Anti-cancer …, 2017 - pubmed.ncbi.nlm.nih.gov
The US Food and Drug Administration (FDA) issued a guidance document in 2010 on
pharmacokinetic (PK) studies in renal impairment (RI) on the basis of observations that …
pharmacokinetic (PK) studies in renal impairment (RI) on the basis of observations that …
[HTML][HTML] A survey of renal impairment pharmacokinetic studies for new oncology drug approvals in the USA from 2010 to early 2015: a focus on development …
JJ Xiao, JS Chen, BL Lum, RA Graham - Anti-Cancer Drugs, 2017 - ncbi.nlm.nih.gov
Abstract The US Food and Drug Administration (FDA) issued a guidance document in 2010
on pharmacokinetic (PK) studies in renal impairment (RI) on the basis of observations that …
on pharmacokinetic (PK) studies in renal impairment (RI) on the basis of observations that …